InvestorWire NewsRoom

InvestorNewsBreak

InvestorNewsBreaks – Astiva Health Notes ‘Outstanding Expansion’ in 2024, Projects ‘Substantial’ Growth for 2025
September 11, 2024

InvestorNewsBreaks – Astiva Health Notes ‘Outstanding Expansion’ in 2024, Projects ‘Substantial’ Growth for 2025

Astiva Health, a fast-growing Medicare Advantage Prescription Drug (“MAPD”) health plan dedicated to reshaping personalized and comprehensive healthcare, is forecasting membership growth for 2025. This year the company has seen “outstanding expansion,” and based on that growth, Astiva Health anticipates have an additional 7,000 members join its unique, personalized plan membership in the upcoming year. According to the announcement, those numbers would represent a substantial 70% increase over its current membership base.

“We are thrilled to continue building on the momentum we’ve achieved this year,” said Astiva Health cofounder and CEO Dr. Tri T. Nguyen in the press release. “Our growth is a testament to the value our culturally aware, personalized healthcare model brings to our members. As we project adding another 7,000 members in 2025, we are committed to expanding our services and enhancing the quality of care we provide.”

To view the full press release, visit https://ibn.fm/sg27b

About Astiva Health

Astiva Health is a fast-growing MAPD health plan committed to redefining personalized and comprehensive healthcare standards. With a mission to elevate the well-being of individuals, Astiva Health specializes in innovative health plans tailored to meet the unique needs of its members. The organization prioritizes a culturally responsive approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Astiva Health’s dedication to serving the underserved population fulfills a critical societal need and also positions the company to tap into a market segment with significant growth potential. By addressing the diverse healthcare needs of its members, Astiva Health aims to create lasting relationships and contribute to the overall well-being of the communities it serves. For more information about the company, visit www.AstivaHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to Astiva are available in the company’s newsroom at https://ibn.fm/Astiva

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Recent NewsBreaks

NewsBreaks Categories

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).